In terms of the broader markets, the BSE mid-cap index rose 0.22 per cent, whereas the BSE small-cap index fell by 0.35 per cent.
The Sensex at the Bombay Stock Exchange breached the 32,000 mark for the first time ever in morning trade.
Meanwhile, TCS, which reported its earnings post market hours on Thursday, closed 2 per cent lower as it failed to meet Street estimates. Bank Nifty turned positive after the release of data and ended 0.21 per cent higher at 23,937.70. During the day, it lost 2.78 per cent to Rs 2,376.10.
Indian equities ended flat on Friday erasing earlier gains.More news: Buffett, Malone explore investment in Sprint
However, pharma and energy shares witnessed buying today with their respective sectoral indices on NSE gaining 0.84 per cent and 0.77 per cent respectively.
BSE IT bled the most, losing 0.95 per cent in trade.
Software services exporter Infosys rallied by 1.63 per cent to Rs 992.25 after the company today reported 1.3 per cent growth in consolidated net profit at Rs 3,483 crore for the June quarter.
Among specific stocks, shares of Biocon surged over 8 per cent after the US Food and Drug Administration approved Biocon and US drug maker Mylan's proposed biosimilar breast cancer drug Trastuzumab.
At NSE, shares of the company went down by 2 per cent to close at Rs 2,397.45.